These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2472631)

  • 1. [Refractory anemia with partial blastosis. A new therapeutic approach].
    Chomienne C; Thomas G; Najean Y; Degos L
    Presse Med; 1989 Jun; 18(23):1159-63. PubMed ID: 2472631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Management of myelodysplastic syndromes].
    Hotta T
    Rinsho Ketsueki; 1990 Apr; 31(4):416-30. PubMed ID: 1696325
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of RAEB-t with intensive chemotherapy and GM-CSF.
    Brito-Babapulle F; Lord JA; Whitmore DN
    Leuk Res; 1989; 13(7):605-7. PubMed ID: 2668647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
    Herrmann F; Lindemann A; Klein H; Lübbert M; Schulz G; Mertelsmann R
    Leukemia; 1989 May; 3(5):335-8. PubMed ID: 2654495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation.
    Saito K; Nakamura Y; Aoyagi M; Waga K; Yamamoto K; Aoyagi A; Inoue F; Nakamura Y; Arai Y; Tadokoro J; Handa T; Tsurumi S; Arai H; Kawagoe Y; Gunnji H; Kitsukawa Y; Takahashi W; Furusawa S
    Int J Hematol; 2000 Apr; 71(3):238-44. PubMed ID: 10846828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
    Estey EH; Kantarjian HM; O'Brien S; Kornblau S; Andreeff M; Beran M; Pierce S; Keating M
    Cytokines Mol Ther; 1995 Mar; 1(1):21-8. PubMed ID: 9384660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined GM-CSF and erythropoietin therapy in myelodysplastic syndrome].
    Egli F; Hofer S; Greminger P; Rhyner K
    Schweiz Med Wochenschr; 1989 Dec; 119(49):1777-80. PubMed ID: 2694367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological molecules in the treatment of hematological disorders.
    Kurzrock R; Talpaz M; Gutterman U
    Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.
    Ashida T; Mayama T; Higashishiba M; Kawanishi K; Miyatake J; Tatsumi Y; Kanamaru A
    Hematology; 2006 Jun; 11(3):179-81. PubMed ID: 17325958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colony-stimulating factors].
    Uhl D
    Med Monatsschr Pharm; 1990 Jun; 13(6):162-4. PubMed ID: 1695708
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) compared to Hyper-CVAD regimen as salvage chemotherapy in relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Liu L; Jiao W; Zhang Y; Qu Q; Li X; Wu D
    Leuk Res; 2015 Mar; 39(3):323-8. PubMed ID: 25638269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of growth factors in severe aplastic anaemia (SAA).
    Hinterberger W; Hoffmann S; Bettelheim P; Geissler K; Maurer D; Muhm M
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():129-30. PubMed ID: 2697425
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes.
    N Engl J Med; 1988 Jul; 319(1):51-3. PubMed ID: 3288869
    [No Abstract]   [Full Text] [Related]  

  • 14. FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.
    Bermúdez A; Pérez-Vázquez G; Insunza A; Baro J; Colorado M; Conde E; Díez-Gallarreta Z; Gutiérrez ML; López-Duarte M; Olalla I; Sanroma P; Yañez L; Iriondo A; Richard C
    Am J Hematol; 2012 Jan; 87(1):42-4. PubMed ID: 22015963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The beneficial effect of 1,25-dihydroxycholecalciferol on the excess of blasts and the myelofibrosis in 2 cases of chronic myeloproliferative syndrome].
    Raya Sánchez JM; Hernández Nieto L; Brito Barroso ML; Hernández García MT
    Med Clin (Barc); 1994 Mar; 102(10):380-2. PubMed ID: 8182985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 17. Small-dose cytosine arabinoside in the treatment of elderly patients with acute leukemia and refractory anemia with excess of blast.
    Satou Y; Kubota T; Yonekura S; Noguchi K; Oobayashi Y; Nagao T; Arimori S
    Tokai J Exp Clin Med; 1986 Oct; 11(4):249-54. PubMed ID: 3617109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
    Cortes-Funes H
    Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
    [No Abstract]   [Full Text] [Related]  

  • 20. GM-CSF treatment and hypokalemia.
    Viens P; Thyss A; Garnier G; Ayela P; Lagrange M; Schneider M
    Ann Intern Med; 1989 Aug; 111(3):263. PubMed ID: 2665594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.